Review Article | Published:

Topology of active, membrane-embedded Bax in the context of a toroidal pore

Cell Death & Differentiationvolume 25pages17171731 (2018) | Download Citation


Bax is a Bcl-2 protein critical for apoptosis induction. In healthy cells, Bax is mostly a monomeric, cytosolic protein, while upon apoptosis initiation it inserts into the outer mitochondrial membrane, oligomerizes, and forms pores that release proapoptotic factors like Cytochrome c into the cytosol. The structures of active Bax and its homolog Bak are only partially understood and the topology of the proteins with respect to the membrane bilayer is controversially described in the literature. Here, we systematically review and examine the protein–membrane, protein–water, and protein–protein contacts of the nine helices of active Bax and Bak, and add a new set of topology data obtained by fluorescence and EPR methods. We conclude based on the consistent part of the datasets that the core/dimerization domain of Bax (Bak) is water exposed with only helices 4 and 5 in membrane contact, whereas the piercing/latch domain is in peripheral membrane contact, with helix 9 being transmembrane. Among the available structural models, those considering the dimerization/core domain at the rim of a toroidal pore are the most plausible to describe the active state of the proteins, although the structural flexibility of the piercing/latch domain does not allow unambiguous discrimination between the existing models.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Additional information

Edited by M. Piacentini


  1. 1.

    Czabotar PE, Lessene G, Strasser A, Adams JM. Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy. Nat Rev Mol Cell Biol. 2014;15:49–63.

  2. 2.

    Martinou J-C, Youle Richard J. Mitochondria in apoptosis: Bcl-2 family members and mitochondrial dynamics. Dev Cell. 2011;21:92–101.

  3. 3.

    Garcia-Saez AJ. The secrets of the Bcl-2 family. Cell Death Differ. 2012;19:1733–40.

  4. 4.

    Youle RJ, Strasser A. The BCL-2 protein family: opposing activities that mediate cell death. Nat Rev Mol Cell Biol. 2008;9:47–59.

  5. 5.

    Strasser A, Cory S, Adams JM. Deciphering the rules of programmed cell death to improve therapy of cancer and other diseases. EMBO J. 2011;30:3667–83.

  6. 6.

    Delbridge AR, Grabow S, Strasser A, Vaux DL. Thirty years of BCL-2: translating cell death discoveries into novel cancer therapies. Nat Rev Cancer. 2016;16:99–109.

  7. 7.

    Westphal D, Dewson G, Czabotar PE, Kluck RM. Molecular biology of Bax and Bak activation and action. Biochim Biophys Acta-Mol Cell Res. 2011;1813:521–31.

  8. 8.

    Lindsten T, Ross AJ, King A, Zong WX, Rathmell JC, Shiels HA, et al. The combined functions of proapoptotic Bcl-2 family members bak and bax are essential for normal development of multiple tissues. Mol Cell. 2000;6:1389–99.

  9. 9.

    Wei MC, Zong WX, Cheng EH, Lindsten T, Panoutsakopoulou V, Ross AJ, et al. Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science. 2001;292:727–30.

  10. 10.

    Reyna DE, Garner TP, Lopez A, Kopp F, Choudhary GS, Sridharan A, et al. Direct activation of BAX by BTSA1 overcomes apoptosis resistance in acute myeloid leukemia. Cancer Cell. 2017;32:490–505.

  11. 11.

    Bleicken S, Garcia-Saez AJ. Bcl-2 proteins: unraveling the details of a complex and dynamic network. Mol Cell Oncol. 2017;5:e1384880.

  12. 12.

    Kim H, Tu HC, Ren D, Takeuchi O, Jeffers JR, Zambetti GP, et al. Stepwise activation of BAX and BAK by tBID, BIM, and PUMA initiates mitochondrial apoptosis. Mol Cell. 2009;36:487–99.

  13. 13.

    Subburaj Y, Cosentino K, Axmann M, Pedrueza-Villalmanzo E, Hermann E, Bleicken S, et al. Bax monomers form dimer units in the membrane that further self-assemble into multiple oligomeric species. Nat Commun. 2015;6:8042–52.

  14. 14.

    Lovell JF, Billen LP, Bindner S, Shamas-Din A, Fradin C, Leber B, et al. Membrane binding by tBid initiates an ordered series of events culminating in membrane permeabilization by Bax. Cell. 2008;135:1074–84.

  15. 15.

    Suzuki M, Youle RJ, Tjandra N. Structure of Bax: coregulation of dimer formation and intracellular localization. Cell. 2000;103:645–54.

  16. 16.

    Moldoveanu T, Liu Q, Tocilj A, Watson M, Shore G, Gehring K. The X-ray structure of a BAK homodimer reveals an inhibitory zinc binding site. Mol Cell. 2006;24:677–88.

  17. 17.

    Todt F, Cakir Z, Reichenbach F, Emschermann F, Lauterwasser J, Kaiser A, et al. Differential retrotranslocation of mitochondrial Bax and Bak. EMBO J. 2015;34:67–80.

  18. 18.

    Cheng EH, Sheiko TV, Fisher JK, Craigen WJ, Korsmeyer SJ. VDAC2 inhibits BAK activation and mitochondrial apoptosis. Science. 2003;301:513–7.

  19. 19.

    Ma SB, Nguyen TN, Tan I, Ninnis R, Iyer S, Stroud DA, et al. Bax targets mitochondria by distinct mechanisms before or during apoptotic cell death: a requirement for VDAC2 or Bak for efficient Bax apoptotic function. Cell Death Differ. 2014;21:1925–35.

  20. 20.

    Lazarou M, Stojanovski D, Frazier AE, Kotevski A, Dewson G, Craigen WJ, et al. Inhibition of Bak activation by VDAC2 is dependent on the Bak transmembrane anchor. J Biol Chem. 2010;285:36876–83.

  21. 21.

    Schellenberg B, Wang P, Keeble James A, Rodriguez-Enriquez R, Walker S, Owens TW, et al. Bax exists in a dynamic equilibrium between the cytosol and mitochondria to control apoptotic priming. Mol Cell. 2013;49:959–71.

  22. 22.

    Edwards AL, Gavathiotis E, LaBelle JL, Braun CR, Opoku-Nsiah KA, Bird GH, et al. Multimodal interaction with BCL-2 family proteins underlies the proapoptotic activity of PUMA BH3. Chem Biol. 2013;20:888–902.

  23. 23.

    Gavathiotis E, Suzuki M, Davis ML, Pitter K, Bird GH, Katz SG, et al. BAX activation is initiated at a novel interaction site. Nature. 2008;455:1076–81.

  24. 24.

    Shamas-Din A, Satsoura D, Khan O, Zhu W, Leber B, Fradin C, et al. Multiple partners can kiss-and-run: Bax transfers between multiple membranes and permeabilizes those primed by tBid. Cell Death Dis. 2014;5:e1277.

  25. 25.

    Czabotar Peter E, Westphal D, Dewson G, Ma S, Hockings C, Fairlie WD, et al. Bax crystal structures reveal how BH3 domains activate Bax and nucleate its oligomerization to induce apoptosis. Cell. 2013;152:519–31.

  26. 26.

    Moldoveanu T, Grace CR, Llambi F, Nourse A, Fitzgerald P, Gehring K, et al. BID-induced structural changes in BAK promote apoptosis. Nat Struct Mol Biol. 2013;20:589–97.

  27. 27.

    Cartron P-F, Gallenne T, Bougras G, Gautier F, Manero F, Vusio P, et al. The first α helix of Bax plays a necessary role in its ligand-induced activation by the BH3-only proteins Bid and PUMA. Mol Cell. 2004;16:807–18.

  28. 28.

    Bleicken S, Zeth K. Conformational changes and protein stability of the pro-apoptotic protein Bax. J Bioenerg Biomembr. 2009;41:29–40.

  29. 29.

    Gavathiotis E, Reyna DE, Davis ML, Bird GH, Walensky LD. BH3-triggered structural reorganization drives the activation of proapoptotic BAX. Mol Cell. 2010;40:481–92.

  30. 30.

    Bleicken S, Jeschke G, Stegmueller C, Salvador-Gallego R, García-Sáez Ana J, Bordignon E. Structural model of active Bax at the membrane. Mol Cell. 2014;56:496–505.

  31. 31.

    Niu X, Brahmbhatt H, Mergenthaler P, Zhang Z, Sang J, Daude M, et al. A small-molecule inhibitor of Bax and Bak oligomerization prevents genotoxic cell death and promotes neuroprotection. Cell Chem Biol. 2017;24:493–506.

  32. 32.

    Bleicken S, Classen M, Padmavathi PV, Ishikawa T, Zeth K, Steinhoff HJ, et al. Molecular details of Bax activation, oligomerization, and membrane insertion. J Biol Chem. 2010;285:6636–47.

  33. 33.

    Brouwer JM, Westphal D, Dewson G, Robin AY, Uren RT, Bartolo R, et al. Bak core and latch domains separate during activation, and freed core domains form symmetric homodimers. Mol Cell. 2014;55:938–46.

  34. 34.

    Zhang Z, Subramaniam S, Kale J, Liao C, Huang B, Brahmbhatt H, et al. BH3-in-groove dimerization initiates and helix 9 dimerization expands Bax pore assembly in membranes. EMBO J. 2016;35:208–36.

  35. 35.

    Dewson G, Kratina T, Czabotar P, Day CL, Adams JM, Kluck RM. Bak activation for apoptosis involves oligomerization of dimers via their alpha6 helices. Mol Cell. 2009;36:696–703.

  36. 36.

    Dewson G, Ma S, Frederick P, Hockings C, Tan I, Kratina T, et al. Bax dimerizes via a symmetric BH3:groove interface during apoptosis. Cell Death Differ. 2012;19:661–70.

  37. 37.

    Iyer S, Bell F, Westphal D, Anwari K, Gulbis J, Smith BJ, et al. Bak apoptotic pores involve a flexible C-terminal region and juxtaposition of the C-terminal transmembrane domains. Cell Death Differ. 2015;22:1665–75.

  38. 38.

    Zhang Z, Zhu WJ, Lapolla SM, Miao YW, Shao YL, Falcone M, et al. Bax forms an oligomer via separate, yet interdependent, surfaces. J Biol Chem. 2010;285:17614–27.

  39. 39.

    Uren RT, O’Hely M, Iyer S, Bartolo R, Shi MX, Brouwer JM, et al. Disordered clusters of Bak dimers rupture mitochondria during apoptosis. Elife 2017;6:e19944.

  40. 40.

    Bleicken S, Landeta O, Landajuela A, Basanez G, Garcia-Saez AJ. Proapoptotic Bax and Bak form stable protein-permeable pores of tunable size. J Biol Chem. 2013;288:33241–52.

  41. 41.

    Qian S, Wang W, Yang L, Huang HW. Structure of transmembrane pore induced by Bax-derived peptide: evidence for lipidic pores. Proc Natl Acad Sci USA. 2008;105:17379–83.

  42. 42.

    Gillies LA, Du H, Peters B, Knudson CM, Newmeyer DD, Kuwana T. Visual and functional demonstration of growing Bax-induced pores in mitochondrial outer membranes. Mol Biol Cell. 2015;26:339–49.

  43. 43.

    Schafer B, Quispe J, Choudhary V, Chipuk JE, Ajero TG, Du H, et al. Mitochondrial outer membrane proteins assist Bid in Bax-mediated lipidic pore formation. Mol Biol Cell. 2009;20:2276–85.

  44. 44.

    Bleicken S, Hofhaus G, Ugarte-Uribe B, Schroder R, Garcia-Saez AJ. cBid, Bax and Bcl-xL exhibit opposite membrane remodeling activities. Cell Death Dis. 2016;7:e2121.

  45. 45.

    Garcia-Saez AJ, Coraiola M, Serra MD, Mingarro I, Muller P, Salgado J. Peptides corresponding to helices 5 and 6 of Bax can independently form large lipid pores. FEBS J. 2006;273:971–81.

  46. 46.

    Mikhailov V, Mikhailova M, Degenhardt K, Venkatachalam MA, White E, Saikumar P. Association of Bax and Bak homo-oligomers in mitochondria. Bax requirement for Bak reorganization and cytochrome c release. J Biol Chem. 2003;278:5367–76.

  47. 47.

    Westphal D, Dewson G, Menard M, Frederick P, Iyer S, Bartolo R, et al. Apoptotic pore formation is associated with in-plane insertion of Bak or Bax central helices into the mitochondrial outer membrane. Proc Natl Acad Sci USA. 2014;111:E4076–4085.

  48. 48.

    Pang Y-P, Dai H, Smith A, Meng XW, Schneider PA, Kaufmann SH. Bak Conformational changes induced by ligand binding: insight into BH3 domain binding and Bak homo-oligomerization. Sci Rep. 2012;2:257.

  49. 49.

    Annis MG, Soucie EL, Dlugosz PJ, Cruz-Aguado JA, Penn LZ, Leber B, et al. Bax forms multispanning monomers that oligomerize to permeabilize membranes during apoptosis. EMBO J. 2005;24:2096–103.

  50. 50.

    Mandal T, Shin S, Aluvila S, Chen HC, Grieve C, Choe JY, et al. Assembly of Bak homodimers into higher order homooligomers in the mitochondrial apoptotic pore. Sci Rep. 2016;6:30763.

  51. 51.

    Alsop AE, Fennell SC, Bartolo RC, Tan IK, Dewson G, Kluck RM. Dissociation of Bak alpha1 helix from the core and latch domains is required for apoptosis. Nat Commun. 2015;6:6841.

  52. 52.

    Li MX, Tan IKL, Ma SB, Hockings C, Kratina T, Dengler MA, et al. BAK α6 permits activation by BH3-only proteins and homooligomerization via the canonical hydrophobic groove. Proc Natl Acad Sci USA. 2017;114:7629–34.

  53. 53.

    Logan J, Hiestand D, Daram P, Huang Z, Muccio DD, Hartman J, et al. Cystic fibrosis transmembrane conductance regulator mutations that disrupt nucleotide binding. J Clin Invest. 1994;94:228–36.

  54. 54.

    Studer RA, Dessailly BH, Orengo CA. Residue mutations and their impact on protein structure and function: detecting beneficial and pathogenic changes. Biochem J. 2013;449:581–94.

  55. 55.

    Piel FB, Steinberg MH, Rees DC. Sickle cell disease. N Engl J Med. 2017;376:1561–73.

  56. 56.

    Meijerink JP, Mensink EJ, Wang K, Sedlak TW, Sloetjes AW, de Witte T, et al. Hematopoietic malignancies demonstrate loss-of-function mutations of BAX. Blood. 1998;91:2991–7.

  57. 57.

    Cheng EH, Levine B, Boise LH, Thompson CB, Hardwick JM. Bax-independent inhibition of apoptosis by Bcl-XL. Nature. 1996;379:554–6.

  58. 58.

    Bleicken S, Hantusch A, Das KK, Frickey T, Garcia-Saez AJ. Quantitative interactome of a membrane Bcl-2 network identifies a hierarchy of complexes for apoptosis regulation. Nat Comm. 2017;8:73.

  59. 59.

    O’Neill KL, Huang K, Zhang J, Chen Y, Luo X. Inactivation of prosurvival Bcl-2 proteins activates Bax/Bak through the outer mitochondrial membrane. Genes Dev. 2016;30:973–88.

  60. 60.

    Sedlak TW, Oltvai ZN, Yang E, Wang K, Boise LH, Thompson CB, et al. Multiple Bcl-2 family members demonstrate selective dimerizations with Bax. Proc Natl Acad Sci USA. 1995;92:7834–8.

  61. 61.

    Cartron PF, Arokium H, Oliver L, Meflah K, Manon S, Vallette FM. Distinct domains control the addressing and the insertion of Bax into mitochondria. J Biol Chem. 2005;280:10587–98.

  62. 62.

    Zhou H, Hou Q, Hansen JL, Hsu YT. Complete activation of Bax by a single site mutation. Oncogene. 2007;26:7092–102.

  63. 63.

    Valentijn AJ, Upton JP, Bates N, Gilmore AP. Bax targeting to mitochondria occurs via both tail anchor-dependent and -independent mechanisms. Cell Death Differ. 2008;15:1243–54.

  64. 64.

    Schinzel A, Kaufmann T, Schuler M, Martinalbo J, Grubb D, Borner C. Conformational control of Bax localization and apoptotic activity by Pro168. J Cell Biol. 2004;164:1021–32.

  65. 65.

    Dewson G, Kratina T, Sim HW, Puthalakath H, Adams JM, Colman PM, et al. To trigger apoptosis, Bak exposes its BH3 domain and homodimerizes via BH3:groove interactions. Mol Cell. 2008;30:369–80.

  66. 66.

    Ferrer PE, Frederick P, Gulbis JM, Dewson G, Kluck RM. Translocation of a Bak C-terminus mutant from cytosol to mitochondria to mediate cytochrome: implications for Bak and Bax apoptotic function. PLoS ONE. 2012;7:e31510.

  67. 67.

    Oh KJ, Singh P, Lee K, Foss K, Lee S, Park M, et al. Conformational changes in BAK, a pore-forming proapoptotic Bcl-2 family member, upon membrane insertion and direct evidence for the existence of BH3-BH3 contact interface in BAK homo-oligomers. J Biol Chem. 2010;285:28924–37.

  68. 68.

    Aluvila S, Mandal T, Hustedt E, Fajer P, Choe JY, Oh KJ. Organization of the mitochondrial apoptotic BAK pore: oligomerization of the BAK homodimers. J Biol Chem. 2013;289:2537–51.

  69. 69.

    Weber K, Harper N, Schwabe J, Cohen GM. BIM-mediated membrane insertion of the BAK pore domain is an essential requirement for apoptosis. Cell Rep. 2013;5:409–20.

  70. 70.

    Nechushtan A, Smith CL, Hsu Y-T, Youle RJ. Conformation of the Bax C-terminus regulates subcellular location and cell death. EMBO J. 1999;18:2330–41.

  71. 71.

    Gahl RF, Tekle E, Tjandra N. Single color FRET based measurements of conformational changes of proteins resulting from translocation inside cells. Methods. 2014;66:180–7.

  72. 72.

    Gahl RF, He Y, Yu S, Tjandra N. Conformational rearrangements in the pro-apoptotic protein, Bax, as it inserts into mitochondria: a cellular death switch. J Biol Chem. 2014;289:32871–82.

  73. 73.

    Bleicken S, Wagner C, García-Sáez Ana J. Mechanistic differences in the membrane activity of Bax and Bcl-xL correlate with their opposing roles in apoptosis. Biophys J. 2013;104:421–31.

  74. 74.

    Fischer AW, Bordignon E, Bleicken S, Garcia-Saez AJ, Jeschke G, Meiler J. Pushing the size limit of de novo structure ensemble prediction guided by sparse SDSL-EPR restraints to 200 residues: the monomeric and homodimeric forms of BAX. J Struct Biol. 2016;195:62–71.

  75. 75.

    Ladokhin AS. Measuring membrane penetration with depth-dependent fluorescence quenching: distribution analysis is coming of age. Biochim Biophys Acta. 2014;1838:2289–95.

  76. 76.

    Flores-Romero H, Garcia-Porras M, Basanez G. Membrane insertion of the BAX core, but not latch domain, drives apoptotic pore formation. Sci Rep. 2017;7:16259.

  77. 77.

    Volkov A, Dockter C, Bund T, Paulsen H, Jeschke G. Pulsed EPR determination of water accessibility to spin-labeled amino acid residues in LHCIIb. Biophys J. 2009;96:1124–41.

  78. 78.

    Segawa TF, Doppelbauer M, Garbuio L, Doll A, Polyhach YO, Jeschke G. Water accessibility in a membrane-inserting peptide comparing overhauser DNP and pulse EPR methods. J Chem Phys. 2016;144:194201.

  79. 79.

    Liu L, Mayo DJ, Sahu ID, Zhou A, Zhang R, McCarrick RM, et al. Determining the secondary structure of membrane proteins and peptides via electron spin echo envelope modulation (ESEEM) spectroscopy. Methods Enzymol. 2015;564:289–313.

  80. 80.

    Carmieli R, Papo N, Zimmermann H, Potapov A, Shai Y, Goldfarb D. Utilizing ESEEM spectroscopy to locate the position of specific regions of membrane-active peptides within model membranes. Biophys J. 2006;90:492–505.

  81. 81.

    Cartron PF, Oliver L, Martin S, Moreau C, LeCabellec MT, Jezequel P, et al. The expression of a new variant of the pro-apoptotic molecule Bax, Baxpsi, is correlated with an increased survival of glioblastoma multiforme patients. Hum Mol Genet. 2002;11:675–87.

  82. 82.

    Cartron PF, Priault M, Oliver L, Meflah K, Manon S, Vallette FM. The N-terminal end of Bax contains a mitochondrial-targeting signal. J Biol Chem. 2003;278:11633–41.

  83. 83.

    Upton JP, Valentijn AJ, Zhang L, Gilmore AP. The N-terminal conformation of Bax regulates cell commitment to apoptosis. Cell Death Differ. 2007;14:932–42.

  84. 84.

    Setoguchi K, Otera H, Mihara K. Cytosolic factor- and TOM-independent import of C-tail-anchored mitochondrial outer membrane proteins. EMBO J. 2006;25:5635–47.

  85. 85.

    McArthur K, Whitehead LW, Heddleston JM, Li L, Padman BS, Oorschot V, et al. BAK/BAX macropores facilitate mitochondrial herniation and mtDNA efflux during apoptosis. Science 2018;359:6378.

  86. 86.

    Kluck RM, Bossy-Wetzel E, Green DR, Newmeyer DD. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science. 1997;275:1132–6.

  87. 87.

    Fernandez-Marrero Y, Bleicken S, Das KK, Bachmann D, Kaufmann T, Garcia-Saez AJ. The membrane activity of BOK involves formation of large, stable toroidal pores and is promoted by cBID. FEBS J. 2017;284:711–24.

  88. 88.

    McMahon HT, Boucrot E. Membrane curvature at a glance. J Cell Sci. 2015;128:1065–70.

  89. 89.

    Zimmerberg J, Kozlov MM. How proteins produce cellular membrane curvature. Nat Rev Mol Cell Biol. 2006;7:9–19.

  90. 90.

    Stachowiak JC, Brodsky FM, Miller EA. A cost-benefit analysis of the physical mechanisms of membrane curvature. Nat Cell Biol. 2013;15:1019–27.

  91. 91.

    Antonsson B, Montessuit S, Sanchez B, Martinou JC. Bax is present as a high molecular weight oligomer/complex in the mitochondrial membrane of apoptotic cells. J Biol Chem. 2001;276:11615–23.

  92. 92.

    Andreu-Fernandez V, Sancho M, Genoves A, Lucendo E, Todt F, Lauterwasser J, et al. Bax transmembrane domain interacts with prosurvival Bcl-2 proteins in biological membranes. Proc Natl Acad Sci USA. 2017;114:310–5.

  93. 93.

    Li W, Cowley A, Uludag M, Gur T, McWilliam H, Squizzato S, et al. The EMBL-EBI bioinformatics web and programmatic tools framework. Nucleic Acids Res. 2015;43(W1):W580–4.

Download references


This work was supported by the DFG Priority Program SPP1601 “New Frontiers in Sensitivity in EPR Spectroscopy” (EB and TEA), the DFG grant BO 3000/5-1 and INST 130/972-1 FUGG (EB), the European Research Council (ERC-2012-StG 309966; SB, CS, and AJG-S), the Forschergruppe 2036 (SB, CS, and AJG-S), and the Cluster of Excellence RESOLV (EXC 1069; SB and EB) funded by the Deutsche Forschungsgemeinschaft. The ESEEM data were recorded in the laboratory of Robert Bittl, FU Berlin. EB would like to thank Gunnar Jeschke and ETH Zurich for the Matlab script used for ESEEM data analysis and the home-made Q-band resonator.

Author information


  1. Department of Chemistry and Biochemistry, Ruhr-University Bochum, Universitätsstr. 150, 44801, Bochum, Germany

    • Stephanie Bleicken
    • , Tufa E. Assafa
    •  & Enrica Bordignon
  2. ZEMOS, Ruhr-University Bochum, Universitätsstr. 150, 44801, Bochum, Germany

    • Stephanie Bleicken
  3. Department of Physics, Freie Universität Berlin, Arnimallee 14, 14195, Berlin, Germany

    • Tufa E. Assafa
    • , Alice Wittig
    •  & Enrica Bordignon
  4. Interfaculty Institute of Biochemistry, Eberhard Karls University Tübingen, Hoppe-Seyler-Str. 4, 72076, Tübingen, Germany

    • Stephanie Bleicken
    • , Carolin Stegmueller
    •  & Ana J. Garcia-Saez


  1. Search for Stephanie Bleicken in:

  2. Search for Tufa E. Assafa in:

  3. Search for Carolin Stegmueller in:

  4. Search for Alice Wittig in:

  5. Search for Ana J. Garcia-Saez in:

  6. Search for Enrica Bordignon in:

Conflict of interest

The authors declare that they have no conflict of interest.

Corresponding authors

Correspondence to Stephanie Bleicken or Enrica Bordignon.

Electronic supplementary material

About this article

Publication history





Issue Date